| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant +1 more) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Single nucleotide variant (synonymous variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (missense variant) | MITF-related disorder +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +1 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | |
| | | Single nucleotide variant (synonymous variant) | MITF-related disorder | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | | Single nucleotide variant (intron variant) | MITF-related disorder | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Duplication (frameshift variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Waardenburg syndrome type 2A | |
| | | Single nucleotide variant (nonsense +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Deletion (intron variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant +1 more) | Waardenburg syndrome type 2A | |
| | | Single nucleotide variant (intron variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Duplication (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Deletion (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Waardenburg syndrome type 2A +2 more | |
| | | Deletion (frameshift variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +5 more | |
| | | Single nucleotide variant (synonymous variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (nonsense) | Waardenburg syndrome type 2A | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | not specified +4 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (nonsense) | not provided | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related disorder +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Waardenburg syndrome type 2A +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | MITF-related disorder | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |